Nevada SJR10 urges Congress to increase funding and research on psychedelic compounds for mental health treatments.
Nevada SJR10 urges Congress to increase federal funding for research into the therapeutic applications of psychedelic compounds for mental health conditions, substance use disorders, and chronic pain. The resolution highlights the potential of compounds like psilocybin and MDMA, citing studies showing their effectiveness and safety in controlled settings. It also calls for a streamlined process for approving research and compassionate use, and advocates for rescheduling certain psychedelics to better reflect their therapeutic value and low potential for abuse.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.